All enrolled sufferers who been given no less than 1 dose of zosuquidar or placebo for the duration of induction have been monitored to the event of adverse occasions (439 patients, 219 on zosuquidar and 210 on placebo). The commonest adverse situations ended up connected with the period of extended https://garrettydhlo.glifeblog.com/27547720/helping-the-others-realize-the-advantages-of-3